SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-207110
Filing Date
2019-07-30
Accepted
2019-07-30 16:43:35
Documents
9
Period of Report
2019-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d783859d8k.htm 8-K 37078
2 EX-4.1 d783859dex41.htm EX-4.1 72650
3 EX-5.1 d783859dex51.htm EX-5.1 12947
4 EX-5.2 d783859dex52.htm EX-5.2 13323
5 EX-10.1 d783859dex101.htm EX-10.1 197403
6 EX-10.2 d783859dex102.htm EX-10.2 218288
7 EX-10.3 d783859dex103.htm EX-10.3 19671
8 GRAPHIC g783859dsp7.jpg GRAPHIC 2274
9 GRAPHIC g783859dspp09.jpg GRAPHIC 5869
  Complete submission text file 0001193125-19-207110.txt   584127
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 19986029
SIC: 3841 Surgical & Medical Instruments & Apparatus